Developmental Surveillance and Screening in Well-Child Care
This program aims to increase the use of validated developmental screening tools and autism-specific screening tools within well-child care, as well as timely referral of children with concerning screening results to appropriate supports and services to promote each child reaching his or her full developmental potential.
In 2006, the American Academy of Pediatrics (AAP) released a policy statement recommending the use of validated developmental screening tools for all children regardless of concern, at the age intervals of 9 months, 18 months and 24 or 30 months. In 2007, the AAP released a policy statement recommending the use of an autism-specific screening tool for all children regardless of concern, at the age intervals of 18 months and 24 months. This presentation will address the need for use of validated developmental screening tools and validated autism-specific screening tools within well-child care to increase early identification of children with delays and timely referral to appropriate supports and services.
Approximately 12-16% of children have disabilities, yet only 30% of children with disabilities are detected before school entrance (Glascoe, 2000). The median age of Autism Spectrum Disorder diagnosis in Wisconsin is 50 months, however greater than 90% of these children had a developmental concern noted in their medical record before 36 months (Baio, 2014). Routine use of validated tools within well-child care increases the early identification of children with delays (Jee, 2010).
- Family Practice Physicians
- Nurse Practitioners
- Physician Assistants
Participants who engage in this educational intervention will be able to:
- Define AAP recommendations for routine and universal developmental screening and autism-specific screening.
- Administer the Ages and Stages Questionnaire 3rd Edition (ASQ-3) within well-child care.
- Administer the Modified Checklist for Autism in Toddlers Revised Version (MCHAT-R) within well-child care.
- Identify appropriate referral resources for children with delays and their families.
In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
Program Planning Committee:
- Sharon Fleishfresser, MD, MPH
- Naomi Kowald, CAPSW
- Geeta Wadhwani, Children's Health Alliance of WI Program Leader
- Cheryl Wendt, MSN, CPNP-PC
Naomi Kowald, CAPSW
Children’s Health Alliance of Wisconsin
Wisconsin's voice for children's health
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.